Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.24B |
| 2 |
Apple
AAPL
|
+$1.14B |
| 3 |
Tesla
TSLA
|
+$1.05B |
| 4 |
Shopify
SHOP
|
+$1B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$901M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.13B |
| 2 |
Netflix
NFLX
|
+$1.1B |
| 3 |
NVO
Novo Nordisk
NVO
|
+$1.03B |
| 4 |
Eli Lilly
LLY
|
+$931M |
| 5 |
Trade Desk
TTD
|
+$899M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.77% |
| 2 | Communication Services | 17.54% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Healthcare | 7% |
| 5 | Financials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Nordson
NDSN
$17.3B
| $8.96M | 0.01% |
+39,477
| New | +$8.7M |
|
377
Sanofi
SNY
$103B
| $8.91M | 0.01% |
188,685
+3,812
| +2% | +$184K |
|
378
Kinetik
KNTK
$3.57B
| $8.68M | 0.01% |
203,134
| – | – |
|
379
Alibaba
BABA
$308B
| $8.66M | 0.01% |
48,475
-593,764
| -92% | -$77.8M |
|
380
Synopsys
SNPS
$77.2B
| $8.57M | 0.01% |
17,371
+166
| +1% | +$93.8K |
|
381
The Mosaic Company
MOS
$7.56B
| $8.48M | ﹤0.01% |
244,425
+29,417
| +14% | +$1.01M |
|
382
Marcus & Millichap
MMI
$1.17B
| $8.4M | ﹤0.01% |
286,129
+3,596
| +1% | +$113K |
|
383
Moody's
MCO
$83.8B
| $7.96M | ﹤0.01% |
16,708
-1,328,598
| -99% | -$670M |
|
|
OMDA
384
Omada Health Inc
OMDA
$1.14B
| $7.9M | ﹤0.01% |
357,386
+107,136
| +43% | +$2.19M |
|
385
Rio Tinto
RIO
$165B
| $7.89M | ﹤0.01% |
+119,586
| New | +$7.39M |
|
386
Amylyx Pharmaceuticals
AMLX
$2.43B
| $7.86M | ﹤0.01% |
+578,659
| New | +$5.45M |
|
387
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
| $7.85M | ﹤0.01% |
120,792
-43,091
| -26% | -$2.69M |
|
388
State Street SPDR S&P Metals & Mining ETF
XME
$4.26B
| $7.78M | ﹤0.01% |
83,491
+1,901
| +2% | +$152K |
|
|
GDEN
389
DELISTED
Golden Entertainment
GDEN
| $7.75M | ﹤0.01% |
328,861
-215,121
| -40% | -$5.73M |
|
390
Canadian National Railway
CNI
$77B
| $6.99M | ﹤0.01% |
74,086
-203
| -0.3% | -$19.6K |
|
391
Neurogene
NGNE
$708M
| $6.83M | ﹤0.01% |
394,089
+226,526
| +135% | +$4.55M |
|
|
WBI
392
WaterBridge Infrastructure LLC
WBI
$1.6B
| $6.78M | ﹤0.01% |
+268,666
| New | +$6.3M |
|
393
Coca-Cola
KO
$374B
| $6.7M | ﹤0.01% |
101,079
-8,775
| -8% | -$604K |
|
|
PVLA
394
Palvella Therapeutics
PVLA
$2.19B
| $6.7M | ﹤0.01% |
+106,910
| New | +$4.77M |
|
|
AVDX
395
DELISTED
AvidXchange
AVDX
| $6.7M | ﹤0.01% |
673,130
-1,587,311
| -70% | -$15.7M |
|
|
AKRO
396
DELISTED
Akero Therapeutics
AKRO
| $6.62M | ﹤0.01% |
139,366
+62,503
| +81% | +$3.03M |
|
397
Onto Innovation
ONTO
$14.1B
| $6.31M | ﹤0.01% |
+48,857
| New | +$5.23M |
|
398
Ormat Technologies
ORA
$6.05B
| $5.76M | ﹤0.01% |
+59,843
| New | +$5.4M |
|
399
Intuit
INTU
$88.9B
| $5.61M | ﹤0.01% |
8,220
+1,349
| +20% | +$972K |
|
|
VIA
400
Via Transportation Inc
VIA
$1.74B
| $5.18M | ﹤0.01% |
+107,745
| New | +$5.33M |
|
Similar funds
Jennison Associates's Q3 2025 Portfolio in Review
As of Q3 2025, Jennison Associates held 667 positions worth $172B, up 1.9% from $169B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Jennison Associates withdrew a net $8.14B in Q3 2025, closing 107 positions and reducing 253 holdings. Its most notable exit was Fair Isaac, an estimated $172M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $627M.
- Jennison Associates's largest Q3 2025 buy was Advanced Micro Devices: 3,874,319 shares worth $627M.
- Jennison Associates added most to Oracle in Q3 2025, an estimated $2.24B increase.
- Jennison Associates's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $1.13B.
- Jennison Associates fully exited Fair Isaac in Q3 2025, selling an estimated $172M.
- Jennison Associates's ten largest holdings make up 47% of its $172B portfolio in Q3 2025.
- Jennison Associates opened 93 new positions and closed 107 in Q3 2025.
- Jennison Associates's portfolio value rose 1.9% quarter-over-quarter to $172B.
Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.